Australia markets closed

Alexion Pharmaceuticals, Inc. (ALXN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
155.01+0.54 (+0.35%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close154.47
Open154.89
Bid150.51 x 1000
Ask156.00 x 800
Day's range154.55 - 155.52
52-week range94.82 - 162.60
Volume1,113,390
Avg. volume2,607,561
Market cap34.079B
Beta (5Y monthly)1.27
PE ratio (TTM)56.99
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
Press releases
  • INVESTIGATION ALERT: Halper Sadeh LLP Investigates MLND, KSHB, GNMK, ALXN; Shareholders are Encouraged to Contact the Firm
    GlobeNewswire

    INVESTIGATION ALERT: Halper Sadeh LLP Investigates MLND, KSHB, GNMK, ALXN; Shareholders are Encouraged to Contact the Firm

    NEW YORK, April 06, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Millendo Therapeutics, Inc. (NASDAQ: MLND) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Tempest Therapeutics, Inc. Upon completion of the merger, Millendo shareholders are expected to own approximately 18.5% of the combined company while pre-merger Tempest stockholders will own approximately 81.5% of the combined company. If you are a Millendo shareholder, click here to learn more about your rights and options. KushCo Holdings, Inc. (OTCQX: KSHB) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Greenlane Holdings, Inc. Under the terms of the merger agreement, KushCo shareholders will receive approximately 0.2546 shares of Greenlane Class A common stock for each share of KushCo common stock, subject to certain adjustments. If you are a KushCo shareholder, click here to learn more about your rights and options. GenMark Diagnostics, Inc. (NASDAQ: GNMK) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Roche for $24.05 per share in cash. If you are a GenMark shareholder, click here to learn more about your rights and options. Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to AstraZeneca PLC for $60.00 in cash and 2.1243 AstraZeneca American Depositary Shares for each Alexion share. If you are an Alexion shareholder, click here to learn more about your rights and options. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com. Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information:Halper Sadeh LLPDaniel Sadeh, Esq.Zachary Halper, Esq.(212) 763-0060sadeh@halpersadeh.comzhalper@halpersadeh.com

  • SHAREHOLDER ALERT: WeissLaw LLP Reminds CATM, KTYB, ALXN and BFTL Shareholders About Its Ongoing Investigations
    PR Newswire

    SHAREHOLDER ALERT: WeissLaw LLP Reminds CATM, KTYB, ALXN and BFTL Shareholders About Its Ongoing Investigations

    If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

  • ALERT: Halper Sadeh LLP Investigates the Following Mergers - FFG, SVBI, MX, ALXN, CATM, MDCA; Shareholders Are Encouraged to Contact the Firm
    PR Newswire

    ALERT: Halper Sadeh LLP Investigates the Following Mergers - FFG, SVBI, MX, ALXN, CATM, MDCA; Shareholders Are Encouraged to Contact the Firm

    Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: